Computed diffusion-weighted imaging of the prostate at 3 T: Impact on image quality and tumour detection

European Radiology

Volumn 23, Issue 11, 2013, Pages 3170-3177

  Rosenkrantz, Andrew B ^a,b   Chandarana, Hersh ^a   Hindman, Nicole ^a   Deng, Fang Ming ^b   Babb, James S ^a   Taneja, Samir S ^a   Geppert, Christian ^c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Siemens Medical Solutions MR R and D   (United States)

Author keywords

b value; Diffusion weighted imaging; MRI; Prostate cancer; Prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE QUALITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATHOLOGIST; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; PROSTATECTOMY; RADIOLOGIST; RETROSPECTIVE STUDY; TUMOR DIAGNOSIS;

AGED; AGED, 80 AND OVER; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84885947886     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2917-8     Document Type: Article

References (32)

1. Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746-757
2. Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46-66
3. Lim HK, Kim JK, Kim KA, Cho KS (2009) Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection - a multireader study. Radiology 250:145-151
4. Haider MA, van der Kwast TH, Tanguay J et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323-328
5. Selnaes KM, Heerschap A, Jensen LR et al (2012) Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology. Invest Radiol 47:624-633
6. Hambrock T, Hoeks C, Hulsbergen-van de Kaa C et al (2012) Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol 61:177-184
7. Somford DM, Hoeks CM, Hulsbergen-van de Kaa CA et al (2013) Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer. Invest Radiol 48:152-157
8. Somford DM, Hambrock T, Hulsbergen-van de Kaa CA et al (2012) Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series. Invest Radiol 47:153-158
9. Kim CK, Park BK, Kim B (2010) Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. AJR Am J Roentgenol 194:1461-1469
10. Vilanova JC, Barcelo-Vidal C, Comet J et al (2011) Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. AJR Am J Roentgenol 196:W715-W722
11. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S (2007) Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 25:146-152
12. Vargas HA, Akin O, Shukla-Dave A et al (2012) Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. Radiology 265:478-487
13. Kobus T, Vos PC, Hambrock T et al (2012) Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. Radiology 265:457-467
14. Kitajima K, Kaji Y, Kuroda K, Sugimura K (2008) High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci 7:93-99
15. Kim CK, Park BK, Kim B (2010) High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol 194:W33-W37
16. Metens T, Miranda D, Absil J, Matos C (2012) What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? Eur Radiol 22:703-709
17. Katahira K, Takahara T, Kwee TC et al (2011) Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol 21:188-196
18. Ohgiya Y, Suyama J, Seino N et al (2012) Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer. Clin Imaging 36:526-531
19. 2). J Magn Reson Imaging 36:198-205
20. Ben-Amitay S, Jones DK, Assaf Y (2012) Motion correction and registration of high b-value diffusion weighted images. Magn Reson Med 67:1694-1702
21. Blackledge MD, Leach MO, Collins DJ, Koh DM (2011) Computed diffusion-weighted MR imaging may improve tumor detection. Radiology 261:573-581
22. Ahmed HU (2009) The index lesion and the origin of prostate cancer. N Engl J Med 361:1704-1706
23. Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M (2010) The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int 106:1607-1611
24. Karavitakis M, Winkler M, Abel P, Livni N, Beckley I, Ahmed HU (2011) Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis 14:46-52
25. Cornfeld DM, Israel G, McCarthy SM, Weinreb JC (2008) Pelvic imaging using a T1W fat-suppressed three-dimensional dual echo Dixon technique at 3T. J Magn Reson Imaging 28:121-127
26. Hori M, Kim T, Onishi H et al (2011) Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T - initial experience. Radiology 258:154-163
27. Langer DL, van der Kwast TH, Evans AJ et al (2008) Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2 - sparse versus dense cancers. Radiology 249:900-908
28. Rosenkrantz AB, Kong X, Niver BE et al (2011) Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map. AJR Am J Roentgenol 196:123-129
29. Liu W, Laitinen S, Khan S et al (2009) Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 15:559-565
30. Wise AM, Stamey TA, McNeal JE, Clayton JL (2002) Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60:264-269
31. Rosenkrantz AB, Sigmund EE, Johnson G et al (2012) Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. Radiology 264:126-135
32. Quentin M, Blondin D, Klasen J et al (2012) Comparison of different mathematical models of diffusion-weighted prostate MR imaging. Magn Reson Imaging 30:1468-1474